BioCentury
ARTICLE | Company News

University of Maryland, Glycocept deal

November 23, 2015 8:00 AM UTC

The University of Maryland granted Glycocept exclusive, worldwide rights to develop and commercialize IP related to modifying the glycosylation profile of mAbs to decrease their binding affinity to F...